Literature DB >> 19528266

Genetics of chromosomally mediated intermediate resistance to ceftriaxone and cefixime in Neisseria gonorrhoeae.

Shuqing Zhao1, Margaret Duncan, Joshua Tomberg, Christopher Davies, Magnus Unemo, Robert A Nicholas.   

Abstract

All strains of Neisseria gonorrhoeae with reduced susceptibility to ceftriaxone and cefixime (cephalosporin-intermediate-resistant [Ceph(i)] strains) contain a mosaic penA allele encoding penicillin-binding protein 2 (PBP 2) with nearly 60 amino acid differences compared to the sequence of wild-type PBP 2, together with a set of resistance determinants (i.e., mtrR, penB, and/or ponA1) that are required for high-level penicillin resistance. To define the individual contributions of these determinants to reduced susceptibility to ceftriaxone and cefixime, we created isogenic strains containing the mosaic penA allele from the Ceph(i) strain 35/02 (penA35) together with one or more of the other resistance determinants and determined the MICs of penicillin G, ceftriaxone, and cefixime. The majority of cefixime resistance is conferred by the penA35 allele, with only a small contribution coming from mtrR and penB, whereas ceftriaxone resistance is nearly equally dependent upon mtrR and penB. Unlike high-level penicillin resistance, the ponA1 allele does not appear to be important for Ceph(i). A strain containing all four determinants has increased resistance to ceftriaxone and cefixime but not to the levels that the donor Ceph(i) strain does, suggesting that Ceph(i) strains, similar to high-level-penicillin-resistant strains, contain an additional unknown determinant that is required to reach donor levels of resistance. Our data also suggest that the original Ceph(i) strains arose from the transformation of penA genes from commensal Neisseria species into a penicillin-resistant strain already harboring mtrR, penB, ponA1, and the unknown gene(s) involved in high-level penicillin resistance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19528266      PMCID: PMC2737842          DOI: 10.1128/AAC.00304-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  35 in total

1.  Overexpression of the MtrC-MtrD-MtrE efflux pump due to an mtrR mutation is required for chromosomally mediated penicillin resistance in Neisseria gonorrhoeae.

Authors:  Wendy L Veal; Robert A Nicholas; William M Shafer
Journal:  J Bacteriol       Date:  2002-10       Impact factor: 3.490

2.  Recombination near the antibiotic resistance locus penB results in antigenic variation of gonococcal outer membrane protein I.

Authors:  D Danielsson; H Faruki; D Dyer; P F Sparling
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

3.  Treatment of uncomplicated gonococcal urethritis by double-dosing of 200 mg cefixime at a 6-h interval.

Authors:  Takashi Deguchi; Mitsuru Yasuda; Shigeaki Yokoi; Ken-Ichiro Ishida; Masayasu Ito; Satoshi Ishihara; Ken Minamidate; Yoshimasa Harada; Kanhin Tei; Kentaro Kojima; Masayoshi Tamaki; Shin-Ichi Maeda
Journal:  J Infect Chemother       Date:  2003-03       Impact factor: 2.211

4.  Multiple antibiotic resistance due to a single mutation in Neisseria gonorrhoeae.

Authors:  M J Maness; P F Sparling
Journal:  J Infect Dis       Date:  1973-09       Impact factor: 5.226

5.  Inheritance of low-level resistance to penicillin, tetracycline, and chloramphenicol in Neisseria gonorrhoeae.

Authors:  P F Sparling; F A Sarubbi; E Blackman
Journal:  J Bacteriol       Date:  1975-11       Impact factor: 3.490

6.  In vitro insertional mutagenesis with a selectable DNA fragment.

Authors:  P Prentki; H M Krisch
Journal:  Gene       Date:  1984-09       Impact factor: 3.688

Review 7.  The genetics of the gonococcus.

Authors:  J G Cannon; P F Sparling
Journal:  Annu Rev Microbiol       Date:  1984       Impact factor: 15.500

8.  Properties of penicillin-binding proteins in Neisseria gonorrhoeae.

Authors:  A G Barbour
Journal:  Antimicrob Agents Chemother       Date:  1981-02       Impact factor: 5.191

9.  Mutations in ponA, the gene encoding penicillin-binding protein 1, and a novel locus, penC, are required for high-level chromosomally mediated penicillin resistance in Neisseria gonorrhoeae.

Authors:  Patricia A Ropp; Mei Hu; Melanie Olesky; Robert A Nicholas
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

10.  Mosaic-like structure of penicillin-binding protein 2 Gene (penA) in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime.

Authors:  Satoshi Ameyama; Shoichi Onodera; Masahiro Takahata; Shinzaburo Minami; Nobuko Maki; Katsuhisa Endo; Hirokazu Goto; Hiroo Suzuki; Yukihiko Oishi
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

View more
  65 in total

1.  Characteristics and dissemination of mosaic penicillin-binding protein 2-harboring multidrug-resistant Neisseria gonorrhoeae isolates with reduced cephalosporin susceptibility in northern Taiwan.

Authors:  Chung-Ter Huang; Muh-Yong Yen; Wing-Wai Wong; Lan-Hui Li; Kun-Yen Lin; Mei-Hui Liao; Shu-Ying Li
Journal:  Antimicrob Agents Chemother       Date:  2010-08-23       Impact factor: 5.191

Review 2.  The use of cephalosporins for gonorrhea: an update on the rising problem of resistance.

Authors:  Juliet E Stoltey; Pennan M Barry
Journal:  Expert Opin Pharmacother       Date:  2012-05-30       Impact factor: 3.889

3.  Molecular Assay for Detection of Genetic Markers Associated with Decreased Susceptibility to Cephalosporins in Neisseria gonorrhoeae.

Authors:  S W Peterson; I Martin; W Demczuk; A Bharat; L Hoang; J Wylie; V Allen; B Lefebvre; G Tyrrell; G Horsman; D Haldane; R Garceau; T Wong; M R Mulvey
Journal:  J Clin Microbiol       Date:  2015-04-15       Impact factor: 5.948

4.  Alanine 501 Mutations in Penicillin-Binding Protein 2 from Neisseria gonorrhoeae: Structure, Mechanism, and Effects on Cephalosporin Resistance and Biological Fitness.

Authors:  Joshua Tomberg; Alena Fedarovich; Leah R Vincent; Ann E Jerse; Magnus Unemo; Christopher Davies; Robert A Nicholas
Journal:  Biochemistry       Date:  2017-02-16       Impact factor: 3.162

5.  Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada.

Authors:  Vanessa G Allen; David J Farrell; Anuradha Rebbapragada; Jingyuan Tan; Nathalie Tijet; Stephen J Perusini; Lynn Towns; Stephen Lo; Donald E Low; Roberto G Melano
Journal:  Antimicrob Agents Chemother       Date:  2010-11-22       Impact factor: 5.191

6.  Equations To Predict Antimicrobial MICs in Neisseria gonorrhoeae Using Molecular Antimicrobial Resistance Determinants.

Authors:  Walter Demczuk; Irene Martin; Pam Sawatzky; Vanessa Allen; Brigitte Lefebvre; Linda Hoang; Prenilla Naidu; Jessica Minion; Paul VanCaeseele; David Haldane; David W Eyre; Michael R Mulvey
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

Review 7.  Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future.

Authors:  Magnus Unemo; William M Shafer
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

8.  Identification of amino acids conferring high-level resistance to expanded-spectrum cephalosporins in the penA gene from Neisseria gonorrhoeae strain H041.

Authors:  Joshua Tomberg; Magnus Unemo; Makoto Ohnishi; Christopher Davies; Robert A Nicholas
Journal:  Antimicrob Agents Chemother       Date:  2013-04-15       Impact factor: 5.191

9.  Quantitative Proteomics of the 2016 WHO Neisseria gonorrhoeae Reference Strains Surveys Vaccine Candidates and Antimicrobial Resistance Determinants.

Authors:  Fadi E El-Rami; Ryszard A Zielke; Teodora Wi; Aleksandra E Sikora; Magnus Unemo
Journal:  Mol Cell Proteomics       Date:  2018-10-23       Impact factor: 5.911

10.  Genome sequencing of a Neisseria gonorrhoeae isolate of a successful international clone with decreased susceptibility and resistance to extended-spectrum cephalosporins.

Authors:  David Hess; Abel Wu; Daniel Golparian; Sarah Esmaili; Will Pandori; Emilee Sena; Jeffrey D Klausner; Pennan Barry; Magnus Unemo; Mark Pandori
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.